explore -WSS

explore

author：hotspot 2025-10-02 19:20:50 - browse：3269

Kara Coluccio, a managing partner at Perspective Group poses for a portrait. -- health coverage from STAT — Kara Coluccio, a managing partner at Perspective Group, says the job market for biotech executives has gotten much tighter. Jessica Rinaldi/Globe Staff

When Crystal Shih Byers left her job at Novartis in 2020, she was excited to make the leap into a smaller startup.

Byers had spent almost nine years at Novartis, most recently helping lead a group that worked on gene therapy. But pharmaceutical companies are large and complex, and she craved more immediate impact. “I was looking for a place where I could be in the room,” she says. She wanted more autonomy, and to feel like her work would reach patients sooner.

At the time, biotech startups were rolling in cash and seeking to capture some of the magic that had fueled Moderna’s meteoric rise. They handed out lots of logo-embossed swag. “Investors were putting a lot of money into stupid science,” Byers says. “There were a lot of companies that lasted for a lot longer than I thought they would on very little data.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Why Novartis is changing the name of its research labs

WSS

What drug price negotiations mean for Medicare Part D

Why Novartis is changing the name of its research labs

How to fix cancer clinical trials' diversity problem

What American doctors can learn from their Israeli counterparts

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

ALS groups 'won't be played again' by the FDA, drug sponsors

Wikipedia

explore

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

Why getting cancer drugs just got harder for rural patients

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

After affirmative action ruling, medical educators look to 'holistic review'

Obesity now affects over 1 billion people worldwide, study finds

Medicare proposal to cover medical devices draws a mixed reaction

What American doctors can learn from their Israeli counterparts

ChatGPT in medicine: STAT answers readers' burning questions

Why getting cancer drugs just got harder for rural patients

entertainment

In search for therapies for solid tumors, companies turn to claudin

Ethical issues complicate the benefits of medical crowdfunding

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

How to fix cancer clinical trials' diversity problem

International team creates first chimeric human

AstraZeneca loses challenge to Medicare drug price negotiation

entertainment

knowledge

focus

Wikipedia